IDH1 or IDH2 mutations have been identified in more than 70% of CNS neoplasms diagnosed as grade II and III astrocytoma, oligodendroglioma, oligoastrocytoma, and secondary glioblastoma. The gene discussed is IDH2; the disease is astrocytoma (excluding glioblastoma).